MP68 Antibody

What is MP68 and what are its established biological functions?

MP68, also known as 6.8 kDa mitochondrial proteolipid protein, is a mitochondrial protein belonging to the small mitochondrial proteolipid family . It functions as a key protein involved in regulating cell growth and proliferation . MP68 plays a crucial role in controlling cell division and differentiation as a cell cycle regulator . The gene encoding MP68 maps to human chromosome 14, which houses over 700 genes and comprises nearly 3.5% of the human genome . MP68 is also referred to by several synonyms including C14orf2, PLPM, ATP5MPL, and ATP synthase membrane subunit 6.8PL .

What types of MP68 antibodies are currently available for research applications?

Several types of MP68 antibodies are available for research:

Most commercially available MP68 antibodies are rabbit polyclonal antibodies that have been affinity-purified using epitope-specific immunogens .

How are MP68 antibodies typically generated and purified?

MP68 antibodies are typically generated using one of two main immunogen approaches:

• Synthetic peptide immunogens: Many MP68 antibodies are developed using synthesized peptides derived from the internal sequence of human MP68 . This approach allows for targeting specific regions of the protein.

• Recombinant protein immunogens: Some antibodies are generated using recombinant human 6.8 kDa mitochondrial proteolipid protein (covering amino acids 1-58) .

The purification process generally involves affinity chromatography using the epitope-specific immunogen. This method yields high purity antibodies (>95% as assessed by SDS-PAGE) . The resulting antibodies are typically stored in phosphate buffered saline (PBS) with glycerol and sodium azide as preservatives at a pH of approximately 7.3-7.4 .

Research Applications and Experimental Design

MP68 exhibits distinct subcellular localization patterns that can be detected using appropriate antibodies:

• Primary localization: As a mitochondrial protein, MP68 is primarily localized in mitochondria, consistent with its classification in the small mitochondrial proteolipid family .

• Cytoplasmic and endoplasmic reticulum presence: Studies have shown that p68 (which may be related to MP68) can be present in the cytoplasm or endoplasmic reticulum .

• Cell surface expression: Low abundance of p68 has been detected on the cell surface .

• Nuclear translocation under stress: Interestingly, under heatshock conditions, p68 has been observed to translocate to the nucleus, suggesting a potential role in stress response mechanisms .

These localization patterns suggest that MP68/p68 may have different functions depending on its subcellular compartmentalization, particularly under various physiological or pathological conditions.

How can MP68 antibodies be utilized in cancer research?

MP68 antibodies serve several important functions in cancer research:

• Identification of tumor-specific antigens: Research has identified a mutant epitope of p68 (mp68) in UV-induced tumors that serves as a tumor-specific antigen. This mp68 epitope can be targeted by T cells for cancer therapy . MP68 antibodies can be used to detect and characterize these tumor-specific antigens.

• Studying dysregulation in cancer: Since dysregulation of MP68 has been linked to cancer and developmental disorders , antibodies can be used to investigate altered expression patterns in tumor tissues compared to normal tissues.

• Therapeutic target identification: By targeting MP68 with specific antibodies, researchers can gain valuable insights into the mechanisms underlying cancer development and potentially identify new therapeutic targets .

• Validating cancer immunotherapy approaches: In studies examining T cell therapy against cancers expressing mp68, antibodies can be used to confirm target expression in tumor cells and monitor changes following treatment .

What is the significance of p68 antibodies in autoimmune research, particularly rheumatoid arthritis?

The p68 autoantigen (which may be distinct from mitochondrial MP68) has significant implications for autoimmune research:

• Diagnostic biomarker: p68 is a target of autoantibodies with high specificity in rheumatoid arthritis (RA), making p68 antibodies potentially valuable diagnostic tools .

• Autoantibody characterization: Studies have shown that autoimmunity to p68 during RA is carried by anti-carbohydrate autoantibodies. The carbohydrate modification of p68 appears to be N-acetylglucosamine .

• Mechanisms of autoimmunity: Research suggests that a shift in the glycosylation pattern of p68, accompanied by unphysiological localization of the antigen, could trigger its antigenicity during RA pathogenesis .

• T cell reactivity: Beyond autoantibodies, p68 is also a target of autoreactive T cells in RA, making it a valuable model for studying T cell-mediated autoimmunity .

Experimental data shows that p68-specific antibodies from RA patients fail to bind to p68 that has been deglycosylated by alkaline β-elimination, O-glycosidase, or periodate treatment, highlighting the importance of glycosylation in autoantibody recognition .

Methodological Approaches and Troubleshooting

For optimal results with MP68 antibodies across different applications:

Western Blot Optimization:

• Sample preparation: Use appropriate lysis buffers with protease inhibitors to prevent degradation of MP68 (approximately 9 kDa) .

• Gel selection: Given the low molecular weight of MP68 (~9 kDa), use high percentage (15-20%) gels for better resolution.

• Transfer conditions: Optimize for small proteins using higher methanol concentrations in transfer buffer.

• Blocking: Consider 5% non-fat dry milk or BSA in TBST for reducing background.

• Antibody dilution: Start with the manufacturer's recommended dilution and optimize as needed.

Immunohistochemistry Optimization:

• Antigen retrieval: Test different methods (heat-induced in citrate buffer pH 6.0 or EDTA buffer pH 9.0).

• Blocking endogenous peroxidase: Use 3% hydrogen peroxide in methanol.

• Antibody dilution: Begin with 1:50-1:100 as recommended for many MP68 antibodies .

• Incubation time and temperature: Typically overnight at 4°C or 1-2 hours at room temperature.

• Detection system: Choose based on sensitivity requirements (ABC, polymer-based systems).

ELISA Optimization:

• Coating concentration: Optimize antigen concentration for plate coating.

• Antibody dilution: Start with recommended ranges (1:2000-1:10000) .

• Incubation conditions: Typically 1-2 hours at room temperature or overnight at 4°C.

• Washing steps: Use PBST (PBS with 0.05% Tween-20) and optimize wash number.

What controls should be included when working with MP68 antibodies?

To ensure experimental validity when working with MP68 antibodies, include:

Positive Controls:

• Cell/tissue lysates known to express MP68 (verified by other methods)

• Recombinant MP68 protein (when available)

• For human samples: MP68 is expressed in various tissues, with notable expression in mitochondria-rich tissues

Negative Controls:

• Samples from MP68 knockout models or cell lines (if available)

• Isotype control antibody (same species and isotype as the MP68 antibody)

• Primary antibody omission control

• Blocking peptide competition (pre-incubation of antibody with immunizing peptide)

Specificity Controls:

• Western blot showing a single band at the expected molecular weight (~9 kDa)

• Peptide competition assays showing signal reduction

• siRNA knockdown of MP68 showing reduced antibody signal

How can researchers establish specificity when working with antibodies to closely related proteins like MP68, mp68, and p68?

The literature indicates potentially confusing nomenclature between MP68 (mitochondrial proteolipid), mp68 (mutant p68 in cancer), and p68 (autoantigen in RA). To establish specificity:

• Sequence verification:

  • Compare the immunogen sequence of the antibody to the target protein sequence

  • Verify whether the antibody targets MP68 mitochondrial protein or other p68-related proteins

  • Check cross-reactivity with other family members

• Expression pattern analysis:

  • MP68 (mitochondrial proteolipid) should localize primarily to mitochondria

  • p68 autoantigen in RA shows cytoplasmic/ER localization with translocation to nucleus under stress

  • mp68 (mutant p68) in cancer cells may show distinct localization patterns

• Molecular weight confirmation:

  • MP68 mitochondrial protein: ~9 kDa

  • Other p68-related proteins may have different molecular weights

• Glycosylation assessment:

  • For p68 autoantigen research: Deglycosylation experiments can differentiate between antibodies recognizing protein versus carbohydrate epitopes

  • Treatment with glycosidases or periodate can reveal if the antibody binds to glycosylated epitopes

What emerging research areas could benefit from MP68 antibody applications?

Several emerging research areas could benefit from MP68 antibody applications:

• Cancer immunotherapy development:

  • Exploring mp68 as a target for T cell receptor (TCR) engineering in adoptive T cell therapy

  • Research has shown that T cells engineered to express a TCR specific for mp68 can reject large, established tumors

  • MP68 antibodies can help identify and characterize tumor cells expressing this target

• Mitochondrial biology and bioenergetics:

  • As a member of the small mitochondrial proteolipid family, MP68 may play roles in mitochondrial function

  • Antibodies could help elucidate MP68's role in ATP synthesis, mitochondrial dynamics, or stress responses

• Autoimmune disease mechanisms:

  • Further investigation of p68's role in rheumatoid arthritis and potentially other autoimmune diseases

  • Studies on glycosylation patterns and their role in breaking immune tolerance

• Antibody engineering platforms:

  • MP68 represents an interesting case study for antibody engineering approaches

  • Recent advances in computational antibody design could be applied to develop more specific antibodies against MP68 or its variants

How can advanced techniques enhance MP68 antibody specificity and research applications?

Advanced techniques that could enhance MP68 antibody research include:

• Biophysics-informed modeling:

  • Computational approaches combining experimental data with biophysical models can help design antibodies with customized specificity profiles

  • Such models can disentangle different binding modes associated with specific ligands, enabling the generation of antibodies with desired properties

• Epitope mapping:

  • Detailed mapping of MP68 epitopes using techniques like hydrogen-deuterium exchange mass spectrometry or cryo-EM

  • Understanding the precise binding sites can help develop more specific antibodies and therapeutic agents

• Single-cell analysis:

  • Combining MP68 antibodies with single-cell technologies to understand heterogeneity in expression and function

  • Single-cell proteomics could reveal cell-specific roles of MP68 in normal and disease states

• Lipid-protein interaction studies:

  • For mitochondrial MP68, studying its interactions with lipid environments using techniques like nanodiscs and bicelles

  • Such approaches have been successful for studying membrane proteins and could reveal important functional aspects of MP68

• Glycobiology approaches:

  • Given the importance of glycosylation for p68 autoantigen recognition in RA , advanced glycobiology techniques could be applied

  • Glycan analysis using mass spectrometry or glycan arrays could help understand the specific glycan structures involved in autoantibody recognition